National Institutes of Health
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing April 5, 2029.
Apr 5, 2029
(979d left)